insulin human · Crystal

What changed in the last 90 days

Every detected change for insulin human, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Insulin, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• asclepias vincetoxicum, echinacea (angustifolia), hypothalamus (suis), hepar suis, kidney (suis), methylcobalamin, gambogia, graphites, nux vomica, phytolacca decandra, 7-oxo-dehydroepiandrosterone 3b-acetate, adenosinum triphosphoricum dinatrum, insulinum (human), pancreas suis, sarcolacticum acidum, proteus (vulgaris)· 1 maker
• ascorbicum acidum, pyridoxinum hydrochloricum, riboflavinum, sarcolacticum acidum, thiaminum hydrochloricum, dhea (dehydroepiandrosterone), adenosinum triphosphoricum dinatrum, alpha-lipoicum acidum, citricum acidum, fumaricum acidum, nadidum, pantothenic acid, acetaldehyde, insulinum (suis), insulinum (human), hepar suis, pancreas suis, phloridzinum, alloxanum, berberis vulgaris, carcinosin, lycopodium clavatum, momordica balsamina, phosphoricum acidum, phosphorus, syzygium jambolanum,· 1 maker
• ascorbicum acidum, pyridoxinum hydrochloricum, riboflavinum, sarcolacticum acidum, thiaminum hydrochloricum, dhea (dehydroepiandrosterone), phloridzinum, adenosinum triphosphoricum dinatrum, alpha-lipoicum acidum, citricum acidum, fumaricum acidum, nadidum, pantothenic acid, acetaldehyde, insulinum (suis), insulinum (human), hepar suis, pancreas suis, phloridzinum, baryta oxalica, alloxanum, berberis vulgaris, carcinosin, lycopodium clavatum, momordica balsamina, phosphoricum acidum, phosphorus,· 1 maker
• cinnamomum, gymnema sylvestre, phosphoricum acidum, syzygium jambolanum, trigonella foenum-graceum, argentum nitricum, chionanthus virginica, hepar suis, pancreas suis, rhus aromatica, sulphur, lycopodium clavatum, chromium picolinate, chromium metallicum, phosphorus, vanadium metallicum, zincum metallicum, murex purpurea, dna, insulinum (human), uranium nitricum· 1 maker
• glycerinum, taraxacum officinale, phytolacca decandra, arsenicum album, bovista, carbo vegetabilis, carboneum sulphuratum, coffea cruda, nitricum acidum, nux vomica, petroleum, phosphoricum acidum, phosphorus, sulphur, acetylsalicylicum acidum, formalinum, glonoinum, insulinum (human), lithium carbonicum, terebinthina, thyroidinum (suis), aceticum acidum, benzoicum acidum, benzyl alcohol, boricum acidum, chlorinum, cortisone aceticum, eugenol, folliculinum, isopropyl palmitate, lacticum acidum,· 1 maker
• glycerinum, taraxacum officinale, phytolacca decandra, arsenicum album, nitricum acidum, nux vomica, petroleum, phosphoricum acidum, phosphorus, acetylsalicylicum acidum, glonoinum, insulinum (human), lithium carbonicum, thyroidinum (suis), aceticum acidum, benzoicum acidum, benzyl alcohol, boricum acidum, chlorinum, cortisone aceticum, eugenol, folliculinum, isopropyl palmitate, lacticum acidum, petroleum jelly, phenyl butazone, plumbum metallicum, potassium sorbate, resorcinum, salicylicum acidum,· 1 maker
• lycopodium clavatum, pancreas suis, dna, insulinum (human), phosphoricum acidum, radium bromatum, uranium nitricum· 1 maker
• lycopodium clavatum, pancreas suis, dna, insulinum, phosphoricum acidum, radium bromatum, uranium nitricum· 1 maker
• lycopodium clavatum, pancreatinum, dna, insulinum, phosphoricum acidum, uranium nitricum, radium bromatum· 1 maker
• human insulin· 2 makers

Common questions

Is Insulin human in shortage right now?

No. FDA does not currently list Insulin human in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Insulin human?

8 companies have marketed Insulin human in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

What does Insulin human cost?

The typical pharmacy pays about $9.03 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.